Objectif Ostoform is a spin-out medical device company from the University of Limerick, Ireland with a range of patented technologies, and the potential to scale, becoming a global leader in the area of ostomy skin health. There is enormous opportunity to address needs in the ostomy market, with 66% of all ileostomy and urostomy patients suffering from skin complications. The company’s first, award winning product, uses a combination of advanced absorbent and non-absorbent materials to prevent acidic output from contacting the patient’s skin. Benefits of this product include healthier skin, better usability, increased patient confidence and improved patient quality of life. Ostoform will release this product in 2018, and major ostomy companies, including B Braun and For Life have already expressed strong interest in distribution.The addressable patient population for Ostoform’s first product is approximately 1,000,000 in the EU and US combined, resulting in an annual market of $725m. The device is typically reimbursed by healthcare systems, resulting in a smoother route to market. This feasibility study will be used to further develop a global reimbursement and go-to-market strategy for Ostoform’s first product. It will also assist in establishing a final cost of manufacture for the device. Champ scientifique medical and health scienceshealth scienceshealth care services Mots‑clés Hydrocolloids Non-Absorbent Ostomy Programme(s) H2020-EU.2.1.2. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies Main Programme H2020-EU.2.1.5. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced manufacturing and processing H2020-EU.2.1.3. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced materials H2020-EU.2.3.1. - Mainstreaming SME support, especially through a dedicated instrument Thème(s) SMEInst-02-2016-2017 - Accelerating the uptake of nanotechnologies advanced materials or advanced manufacturing and processing technologies by SMEs Appel à propositions H2020-SMEInst-2016-2017 Voir d’autres projets de cet appel Sous appel H2020-SMEINST-1-2016-2017 Régime de financement SME-1 - SME instrument phase 1 Coordinateur OSTOFORM LIMITED Contribution nette de l'UE € 50 000,00 Adresse BLOCK A MARLINSTOWN OFFICE PARK N91 W5NN Mullingar Co Westmeath Irlande Voir sur la carte PME L’entreprise s’est définie comme une PME (petite et moyenne entreprise) au moment de la signature de la convention de subvention. Oui Région Ireland Eastern and Midland Mid-East Type d’activité Private for-profit entities (excluding Higher or Secondary Education Establishments) Liens Contacter l’organisation Opens in new window Participation aux programmes de R&I de l'UE Opens in new window Réseau de collaboration HORIZON Opens in new window Coût total € 71 429,00